COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.